Low libido is one of the most common complaints Dr. Katherine Ortiz hears in her practice 

and one of the least likely to be addressed directly in standard medical care. PT-141 is a peptide that takes a fundamentally different approach to sexual health than anything most people have encountered. Here's what it is and how it works.

What is PT-141 and how does it work?

PT-141 (generic name: bremelanotide) is a synthetic peptide that activates melanocortin receptors in the central nervous system — specifically in the brain regions responsible for sexual desire and arousal. Unlike medications such as Viagra or Cialis, which work by increasing blood flow to genital tissue, PT-141 works upstream: it activates the neurological pathways that generate desire itself. This makes it effective for both men and women, and particularly valuable for patients whose low libido is neurological or psychological in origin rather than purely physical.

Why Is PT-141 Different From Other Libido Treatments?

Most treatments for sexual dysfunction address the physical mechanics — blood flow, tissue sensitivity, hormonal levels. These matter, and hormone optimization (particularly testosterone restoration in both sexes) addresses an important layer of sexual health. But many people with adequate hormone levels still experience low or absent libido — because desire is a brain event before it is a physical one.

PT-141 targets the melanocortin system, which plays a central role in regulating sexual motivation. When this system is activated, patients experience genuine desire — not just the physical capacity for sex, but the neurological drive toward it. Patients often describe this as libido returning to how it felt years earlier, rather than a pharmaceutical effect that feels artificial.

This mechanism also means PT-141 works for both men and women — which distinguishes it from the currently available oral medications for sexual dysfunction, most of which are approved for one sex only.

Who Is PT-141 Appropriate For?

Who benefits most from PT-141?

PT-141 is most appropriate for:

• Women with hypoactive sexual desire disorder (HSDD) — the clinical term for persistently low or absent sexual desire that causes distress. This is the most common female sexual complaint and is significantly undertreated.

• Men with low libido — particularly those whose testosterone has been optimized but who still experience low desire, or those for whom the physical mechanics are intact but motivation is absent

• Patients on antidepressants — SSRIs and SNRIs frequently suppress libido as a side effect; PT-141 can restore desire without discontinuing necessary medication

• Perimenopausal and postmenopausal women — for whom the drop in estrogen and testosterone converges with neurological changes that affect sexual motivation

• Men and women experiencing stress-related libido suppression — in which the brain's threat-response system is overriding the desire system

PT-141 is not appropriate for patients with uncontrolled hypertension, as it can temporarily raise blood pressure. A clinical evaluation and blood pressure screening are standard before prescribing.

How Is PT-141 Administered and How Quickly Does It Work?

PT-141 is administered via subcutaneous injection, typically 45 minutes to 1.5 hours before anticipated sexual activity. It is not a daily medication — it is used situationally, as needed. The FDA-approved version (Vyleesi) is a prefilled autoinjector; compounded versions allow for dose customization.

How long does PT-141 last?

The effects of PT-141 typically onset within 45–60 minutes and can last 6–12 hours, with the peak window of enhanced desire occurring in the first few hours after administration. Most patients find the effect feels natural rather than forced — an increase in receptivity and motivation, not an artificial override.

Does PT-141 Work for Women?

Yes — and this is significant. PT-141 (as Vyleesi) is one of very few FDA-approved treatments specifically for female sexual desire disorder. Most sexual health treatments in clinical use were developed primarily for men. The melanocortin mechanism PT-141 targets is relevant to female desire in the same way it is for male desire — making it one of the more genuinely sex-neutral tools in this space.

Women using PT-141 at DNA Wellness typically describe it as reactivating desire they thought they had simply lost — particularly women in the perimenopause and post-menopause transition for whom this change had become normalized.

Can PT-141 Be Used With Hormone Therapy?

Yes, and the combination is often more effective than either approach alone. Hormone optimization — restoring testosterone (and estrogen, where appropriate) to optimal levels — addresses the hormonal foundation of sexual health. PT-141 addresses the neurological layer. For patients who have undergone hormone optimization but still experience low desire, adding PT-141 often produces the results that hormone therapy alone couldn't achieve.

Frequently Asked Questions About PT-141

Does PT-141 work for men with erectile dysfunction? PT-141 addresses desire and arousal through the nervous system, which can improve erectile function as a downstream effect of increased desire. It is not a substitute for PDE5 inhibitors (Viagra, Cialis) in cases of primarily vascular erectile dysfunction, but it addresses a layer those medications do not — the neurological drive toward desire and arousal.

What are the side effects of PT-141? The most common side effects are nausea, flushing, and temporary blood pressure elevation. Nausea is the most frequently reported and typically resolves within 1–2 hours. Administering the injection at the thigh rather than the abdomen may reduce nausea. Starting with a lower dose is often recommended for first-time users.

Is PT-141 FDA approved? Yes. Bremelanotide (PT-141) was approved by the FDA in 2019 as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women. Compounded formulations allow for dose customization and are prescribed off-label for men and postmenopausal women.

How often can PT-141 be used? The FDA-approved guidance recommends no more than one dose per 24 hours and no more than approximately eight doses per month, due to the potential for blood pressure effects with frequent use. Clinical protocols vary.

Is PT-141 the same as the "female Viagra"? PT-141 and flibanserin (Addyi) — often called "female Viagra" — both target HSDD but work through entirely different mechanisms. Flibanserin is a daily oral medication that acts on serotonin and dopamine receptors; PT-141 is an as-needed injectable that activates melanocortin receptors. They are not interchangeable.

If low libido has been affecting your quality of life or your relationship — and you haven't found an answer in standard care — Dr. Katherine Ortiz at DNA Wellness and Longevity Institute in Bonita Springs evaluates sexual health as a medical concern, not an afterthought. PT-141 consultations include hormone panel review, blood pressure screening, and a complete picture of what may be contributing.

Book your sexual health consultation → (239) 250-7930 | defynaturalaging.com